Hubungan Rasio Neutrofil Limfosit dan Rasio Platelet Limfosit dengan Stadium Kanker Payudara di RSUD Dr. Pirngadi Medan  Periode Januari - Desember 2022

Nurul Razoki Yonianda Panjaitan; Adi Rizka; Khairunnisa Khairunnisa

doi:10.55606/detector.v4i2.6108

Authors

Nurul Razoki Yonianda Panjaitan Universitas Malikussaleh
Adi Rizka RSUD Cut Meutia
Khairunnisa Khairunnisa RSUD Cut Meutia

DOI:

https://doi.org/10.55606/detector.v4i2.6108

Keywords:

Breast Cancer, Inflammatory Markers, NLR, PLR, Stage

Abstract

Cancer is the main cause of death in the world, in 2020 approximately 10 million deaths were recorded due to cancer. Based on estimates Globocan, International Agency for Research on Cancer (IARC) In 2020, breast cancer ranks first in the most frequently diagnosed cancer cases with a total incidence of 2.3 million new cases and 685,000 deaths. The neutrophil lymphocyte ratio and the platelet lymphocyte ratio are inflammatory markers that are easy to measure. NLR and PLR can predict cancer development in relation to stage. The higher the NLR and PLR values, the higher the level of development and the worse the degree of cell differentiation. This study aims to determine the relationship between the neutrophil lymphocyte ratio and the platelet lymphocyte ratio with the stage of breast cancer in RSUD DR.The research is analytical research with design cross-sectional against 64 respondents. Samples were taken by technique total sampling. Data were collected using secondary data from medical records and analyzed using the Spearman correlation test. The results of the study showed that the value of data on the ratio of neutrophil lymphocytes to the stage of breast cancer was p=0.003, data on the ratio of platelet lymphocytes to the stage of breast cancer was found to be p=0.002. The conclusion of this study is that there is a relationship between the neutrophil lymphocyte ratio and the platelet lymphocyte ratio with the stage of breast cancer.

Downloads

Download data is not yet available.

References

Ayu, D., Nastiti, W., Agung, W., Cahyawati, S. N., & Panghiyangani, R. (2022). Korelasi rasio neutrofil limfosit dengan lama rawat inap: Studi pada pasien lanjut usia di ruang rawat penyakit dalam RSUD Ulin Banjarmasin. Homeostatis, 5(1), 127–134

Deanasa, R. S., Umar, M., & Fitri, A. D. (2022). Overall survival for stage III breast cancer patients at Dr. Mohammad Hoesin General Hospital Palembang and the influencing factors. Indonesian Journal of Cancer, 16(4), 231–234

Dwi, E., Sihite, O., Nurchayati, S., Hasneli, Y., et al. (2019). Gambaran tingkat pengetahuan tentang kanker payudara dan perilaku periksa payudara sendiri (SADARI). Jurnal Ners Indonesia, 10(1), 8–20.

Farag, C. M., Antar, R., Akosman, S., Ng, M., & Whalen, M. J. (2023). What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types. Oncotarget, 4(2), 33–38.

Gago-Dominguez, M., Matabuena, M., Redondo, C. M., Patel, S. P., Carracedo, A., Ponte, S. M., et al. (2020). Neutrophil to lymphocyte ratio and breast cancer risk: Analysis by subtype and potential interactions. Scientific Reports, 10(1).

Giannakeas, V., Kotsopoulos, J., Brooks, J. D., Cheung, M. C., Rosella, L., Lipscombe, L., et al. (2022). Platelet count and survival after cancer. Cancers, 14(3).

Gong, Z., Xin, R., Li, L., Lv, L., & Wu, X. (2022). Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis. International Journal of Biological Markers, 37, 339–348.

Graeme, J. K., Guthrie, A., Kac, B., Csdr, A., Pgh, A., Dcm, A., & Sjc. (2013). The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer. Critical Reviews in Oncology/Hematology, 88(1), 218–230.

Gusti, I., Ari, N., Satriya Wibawa, A., Bagus Suryawisesa, I., Ketut Widiana, I., Gede, I., et al. (2020). Hubungan antara platelet lymphocyte ratio (PLR) dengan subtipe kanker payudara pada pasien kanker payudara di Rumah Sakit Umum Pusat Sanglah, Denpasar. Intisari Sains Medis, 11(3), 1475–1481.

Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V., & Sood, A. K. (2018). The platelet lifeline to cancer: Challenges and opportunities. Cancer Cell, 33, 965–983.

International Agency for Research on Cancer. (2020). The global cancer observatory: Breast (pp. 1–2)

Iskandar, M., Tendean, M., Salem, B., & Langi, F. G. (2023). Korelasi antara neutrophil-to-lymphocyte ratio dan kadar carcinoembryonic antigen pra-pasca operasi pada kanker kolorektal. Medical Scope Journal, 5(2), 270–278.

Jadoon, S. K., Soomro, R., Ahsan, M. N., Khan, R. M. I., Iqbal, S., Yasmin, F., et al. (2023). Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study. Medicine, 102(20), E33811.

Keramati, M. R., Elyasinia, F., Keramati, M. R., Ahmadi, F., Rezaei, S., Ashouri, M., et al. (2017). Neutrophil-lymphocyte ratio in different stages of breast cancer. Acta Medica Iranica, 55.

Lu, Q., Qin, T., Xu, F., Zeng, Y., Xia, W., Zheng, Q., et al. (2018). Clinical implication of platelet-lymphocyte ratio and PD-L1 in breast cancer patients. Translational Cancer Research, 7(3), 659–667.

Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021). Breast cancer—Epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—An updated review. Cancers, 13.

Mardiah, H., Ginting, R. N. A., Rahmadhany, H., & Sitorus, E. R. D. (2021). Correlation between age and body mass index (BMI) with histopathological features of breast cancer patients in RSUP Haji Adam Malik Medan. Indonesian Journal of Cancer, 15(2), 46.

Ningsih, I., Fallo, Y., Sidharta, R. A., & Gunawan, L. S. (2018). Korelasi antara neutrophyl lymphocyte ratio dengan stadium kanker pada pasien kanker payudara. Biomedika, 9(2), 63–69.

Prakoeswa, F. R. (2020). Peranan sel limfosit dalam imunologi: Artikel review. Jurnal Sains dan Kesehatan, 2(4), 525–537.

Purwati, E., Indriani, V., & Permatasari, O. (2022). Hubungan antara rasio neutrofil-limfosit terhadap kejadian metastasis intraperitoneal pada pasien karsinoma musinosum ovari di RSUD Prof. Dr. Margono Soekarjo tahun 2017–2020. Indonesian Journal of Obstetrics & Gynecology Science, 5(2), 76–83.

Puspa Ningrum, M., & Sri Ratna Rahayu, R. (2021). Determinan kejadian kanker payudara pada wanita usia subur (15–49 tahun). IJPHN, 1(3), 362–370.

Rahayu, S. A., & Arania, R. (2018). Hubungan usia dan paritas dengan kejadian kanker payudara di RSUD Dr. H. Abdul Moeloek Bandar Lampung tahun 2017. Jurnal Ilmu Kedokteran dan Kesehatan, 5(1), 44–50.

Rizka, A., Khalilul Akbar, M., & Putri, N. A. (2022). Carcinoma mammae sinistra T4BN2M1 metastasis pleura. Averrous: Jurnal Kedokteran dan Kesehatan Malikussaleh, 8(1), 23–31.

Wiranata, S., Anjani, I. A. W., Saputra, I. P. G. S., Sadvika, I. G. A. S., Prabawa, I. P. Y., Supadmanaba, I. G., et al. (2020). Pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as a stage determination in breast cancer. Open Access Macedonian Journal of Medical Sciences, 8(B), 1058–1063.

Xiong, S., Dong, L., & Cheng, L. (2021). Neutrophils in cancer carcinogenesis and metastasis. Journal of Hematology and Oncology, 14, 33–37.

Yersal, Ö., Çetinkünar, S., Aktimur, R., Aziret, M., Özdas, S., Erdem, H., et al. (2017). Neutrophil/lymphocyte and platelet/lymphocyte ratios are not different among breast cancer subtypes. Asian Pacific Journal of Cancer Prevention, 18(8), 2227–2231.

Yuswar, T., & Nurlisis. (2018). Keterlambatan pemeriksaan kanker payudara di RSUD Arifin Achmad Provinsi Riau tahun 2016. Jurnal Kesehatan Komunitas, 4(1), 33–39.